This session highlights work from an NHLBI-sponsored program that fosters collaborations among researchers studying fibrosis in the lung and other organ systems that aims to characterize mechanisms of aberrant fibrosis in different organ systems, develop novel therapeutic strategies to lessen organ fibrosis, and improve technologies to study fibrosis.